A mathematical model simulated patient outcomes when given caregiver support or an expensive Alzheimer’s drug to determine cost and health benefits.

During the Jan. 28 Alzheimer's Drug Discover Foundation lecture, panelists said the tests will revolutionize diagnosis and ...

A global expert review has identified a shingles vaccine and two existing drugs as leading candidates for repurposing against ...

In 2021, the fda approved a treatment that claims to stop Alzheimer's at the source, removing the plaques in the brain long thought to cause the symptoms of the disease. But, as is often the case, ...

One of the first Australians to receive the groundbreaking treatment says it has helped restore clarity, as access and cost ...

The hunt for blockbuster drugs has sent pharmaceutical companies into llama farms, outer space, and the soils of Easter ...

Despite its strong influence, APOE is not the sole cause of Alzheimer’s or other dementias. Even among people with the ...

Biogen Inc. BIIB on Friday reported better-than-expected fourth-quarter earnings, with adjusted EPS of $1.99, beating the consensus of $1.59. The Alzheimer's drug maker reported revenues of $2.28 ...

Ruth Talbot, 77, lives with Alzheimer’s and travels to a Gold Coast clinic every month for infusions of donanemab, a newly ...

An international study has confirmed that at-home blood collection in the form of a finger-prick test can accurately ...

Losing the job he'd held for three decades was the first real sign something was wrong, writes physician Brent Beasley in the ...

A new study finds THC, when combined with an anti-inflammatory drug, improved memory and reduced Alzheimer’s-related brain damage in mice, raising hope for future treatment.